Endoscopic mucosal resection for Barrett’s neoplasia: Long-term outcomes from the largest Canadian single-center experience
While the success rate of EMR for BE is excellent, this study highlights substantial long-term risk of neoplastic recurrence, underscoring the need for indefinite surveillance for patients who had HGD or EAC.
Authors
- Natalia Causada Calo (ORCID: https://orcid.org/0000-0003-3828-1031)
- Christopher Teshima (ORCID: https://orcid.org/0000-0002-5525-8565)
- Catherine Streutker (ORCID: https://orcid.org/0000-0002-3582-438X)
- Yusuke Fujiyoshi (ORCID: https://orcid.org/0000-0002-5893-6552)
- Daniel Kai Long Tham (ORCID: https://orcid.org/0000-0002-9835-0775)
- Mary Raina Angeli Fujiyoshi (ORCID: https://orcid.org/0000-0002-5860-9164)
- Norman E. Marcon (ORCID: https://orcid.org/0000-0003-2799-7982)
- Kareem Khalaf (ORCID: https://orcid.org/0000-0002-5534-7533)
- Jeffrey D. Mosko (ORCID: https://orcid.org/0000-0003-2983-524X)
- Gary R. May
Institutions
- St. Michael's Hospital (CA)
- University of Ottawa (CA)
- University of Toronto (CA)
- Ottawa Hospital (CA)
- Ottawa Hospital Research Institute (CA)
Publication Details
- Journal
- Endoscopy International Open
- Published
- 2025-06-17
- DOI
- https://doi.org/10.1055/a-2602-8961
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00